FDA decisions could ‘slow to crawl’ because of government shutdownExperts have said the ongoing government shutdown may already have delayed approval and launch of new drugs, as Share XFDA decisions could ‘slow to crawl’ because of government shutdownhttps://pharmaphorum.com/news/fda-decisions-could-slow-to-crawl-because-of-government-shutdown/
FDA delays review of peanut allergy drug amid Trump shutdownOne of the first pharma victims of the current partial shutdown of the US government has emerged after Share XFDA delays review of peanut allergy drug amid Trump shutdownhttps://pharmaphorum.com/news/fda-delays-review-of-peanut-allergy-drug-amid-trump-shutdown/
Pfizer to hike prices of 41 drugs despite Trump criticismPfizer plans to raise the prices of 41 prescription drugs in January, despite falling foul of President Trump, Share XPfizer to hike prices of 41 drugs despite Trump criticismhttps://pharmaphorum.com/news/pfizer-to-hike-prices-of-41-drugs-despite-trump-criticism/
Democrats vow to tackle drug prices after midterm victoryDrug companies could come under increased pressure to lower prices in the US, after the opposition Democrat party Share XDemocrats vow to tackle drug prices after midterm victoryhttps://pharmaphorum.com/news/democrats-vow-to-tackle-drug-prices-after-midterm-victory/
Trump signs legislation to tackle opiate addictionPresident Donald Trump has signed new legislation into law that he hopes will “end the scourge” of addiction Share XTrump signs legislation to tackle opiate addictionhttps://pharmaphorum.com/news/trump-signs-legislation-to-tackle-opiate-addiction/
Novo Nordisk hints at US price cuts after Q2 sales fallDanish pharma Novo Nordisk posted second-quarter operating profit in line with forecasts but hinted about the possibility of Share XNovo Nordisk hints at US price cuts after Q2 sales fallhttps://pharmaphorum.com/news/novo-nordisk-price-reductions/
Novartis freezes drug prices in a nod to TrumpNovartis has announced it would not raise drug prices in the US this year, while Merck & Co Share XNovartis freezes drug prices in a nod to Trumphttps://pharmaphorum.com/news/novartis-freezes-drug-prices-in-a-nod-to-trump/
Pfizer backed off, but the price hike game continuesDonald Trump may have convinced the US pharma giant Pfizer to defer a price increase for dozens of Share XPfizer backed off, but the price hike game continueshttps://pharmaphorum.com/news/pfizer-backed-off-but-the-price-hike-game-continues/
Pfizer defers drug price hike after Trump phone callPfizer has decided to defer the recent drug price increase after a long discussion with president Trump and Share XPfizer defers drug price hike after Trump phone callhttps://pharmaphorum.com/news/pfizer-defers-drug-price-hike-after-trump-phone-call/
